BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38361348)

  • 1. Thyroid poorly differentiated carcinoma metastatic to pancreas diagnosed by fine-needle aspiration and demonstrating a novel BRAF fusion.
    Ahmadian SS; Jones D; Wakely P; Lott Limbach AA
    Cytopathology; 2024 May; 35(3):408-411. PubMed ID: 38361348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of BRAF V600E in Reducing AUS/FLUS Diagnosis in Thyroid Fine Needle Aspiration.
    Yin L; Tang Y; Yu S; Wang C; Xiao M; Wang Y; Liu SJ; Gao L; Huang K; Jin L
    Endocr Pathol; 2019 Dec; 30(4):312-317. PubMed ID: 31529211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of BRAF V600E mutation detection of fine-needle aspiration biopsy on diagnosis and treatment guidance of papillary thyroid carcinoma.
    Qi W; Shi C; Zhang P; Feng L; Wang J; Chen D
    Pathol Res Pract; 2020 Aug; 216(8):153037. PubMed ID: 32703500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Value and Challenges of BRAF V600E Molecular Testing and Thyroid Fine-Needle Aspiration Cytology: A Retrospective Study from a Tertiary Institution in Southern Hunan Province, China.
    Lan Z; Yang F; Zhang J; Lan Y; Li H; He R
    Acta Cytol; 2023; 67(6):629-638. PubMed ID: 37708867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRAF genetic heterogeneity in papillary thyroid carcinoma and its metastasis.
    Walts AE; Pao A; Sacks W; Bose S
    Hum Pathol; 2014 May; 45(5):935-41. PubMed ID: 24746198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant-specific BRAF and CD117 immunocytochemistry potentially facilitate risk stratification for papillary thyroid carcinoma in fine-needle aspiration biopsy specimens.
    Meng Z; Lu J; Wu H; Zhao Y; Luo Y; Gao J; Zhu Q; Jiang Y; Li W; Liang Z
    Tumour Biol; 2016 Jan; 37(1):611-8. PubMed ID: 26240026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid Fine Needle Aspiration, the Bethesda System, and the BRAFV600E Mutation in Papillary Thyroid Carcinoma: Association and Prediction for Biopsy.
    Galán-García ME; Martínez-Martin MS; Araujo-Ruano EJ; Loro-Ferrer JF; Saavedra-Santana P; Salido-Ruiz E; Cabrera-Galván JJ
    Acta Cytol; 2023; 67(4):346-356. PubMed ID: 36592623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of the BRAF(V600E) mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection: an easy tool to improve the preoperative diagnosis.
    Marchetti I; Iervasi G; Mazzanti CM; Lessi F; Tomei S; Naccarato AG; Aretini P; Alberti B; Di Coscio G; Bevilacqua G
    Thyroid; 2012 Mar; 22(3):292-8. PubMed ID: 22181337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological characteristics of thyroid cancer in the federal state of Salzburg.
    Rendl G; Rodrigues M; Schweighofer-Zwink G; Hutter J; Hittmair A; Zellinger B; Hauser-Kronberger C; Pirich C
    Wien Klin Wochenschr; 2017 Aug; 129(15-16):540-544. PubMed ID: 28493027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papillary Thyroid Carcinoma BRAF Immunopositivity.
    Erickson LA; Chen B
    Mayo Clin Proc; 2021 Jan; 96(1):267-268. PubMed ID: 33413831
    [No Abstract]   [Full Text] [Related]  

  • 11. Utility of BRAF mutation detection in fine-needle aspiration biopsy samples read as "suspicious for papillary thyroid carcinoma".
    Jara SM; Bhatnagar R; Guan H; Gocke CD; Ali SZ; Tufano RP
    Head Neck; 2015 Dec; 37(12):1788-93. PubMed ID: 24989827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma.
    Paek SH; Kim BS; Kang KH; Kim HS
    World J Surg Oncol; 2017 Nov; 15(1):202. PubMed ID: 29132392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation between Ultrasound-guided Fine-needle Aspiration Combined with BRAF
    Zhang Y; Luo YK; Zhang Y; Zhang MB; Guang Y; Xie F; Jiang B; Tang J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Aug; 41(4):517-523. PubMed ID: 31484615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine Needle Biopsy Versus Core Needle Biopsy Combined With/Without Thyroglobulin or BRAF 600E Mutation Assessment for Detecting Cervical Nodal Metastasis of Papillary Thyroid Carcinoma.
    Zhang X; Zhang X; Du W; Dai L; Luo R; Fang Q; Ge H
    Front Endocrinol (Lausanne); 2021; 12():663720. PubMed ID: 33912138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic metastasis of papillary thyroid carcinoma preoperatively diagnosed by endoscopic ultrasound-guided fine-needle aspiration biopsy: a case report with review of literatures.
    Murakami Y; Shimura T; Okada R; Kofunato Y; Ishigame T; Yashima R; Nakano K; Suzuki S; Takenoshita S
    Clin J Gastroenterol; 2018 Dec; 11(6):521-529. PubMed ID: 29948817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of fine needle aspiration BRAF(V600E) mutation analysis in papillary thyroid cancer: a systematic review and meta-analysis.
    Fnais N; Soobiah C; Al-Qahtani K; Hamid JS; Perrier L; Straus SE; Tricco AC
    Hum Pathol; 2015 Oct; 46(10):1443-54. PubMed ID: 26232865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRAF(V600E) mutation analysis of liquid-based preparation-processed fine needle aspiration sample improves the diagnostic rate of papillary thyroid carcinoma.
    Chang H; Lee H; Yoon SO; Kim H; Kim A; Kim BH
    Hum Pathol; 2012 Jan; 43(1):89-95. PubMed ID: 21774961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between macrocalcification and papillary thyroid carcinoma and corresponding valuable diagnostic tool: retrospective study.
    Ye M; Wu S; Zhou Q; Wang F; Chen X; Gong X; Wu W
    World J Surg Oncol; 2023 May; 21(1):149. PubMed ID: 37194091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenging diagnosis of two neoplasms, Langerhans cell histiocytosis and papillary thyroid carcinoma, from fine needle aspiration of the thyroid by cell-block immunocytochemistry and molecular testing for BRAF V600E mutation.
    Zaidi A; Gautam U; Srinivasan R; Bal A; Prakash G; Sood A
    Cytopathology; 2020 Nov; 31(6):598-601. PubMed ID: 32150778
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.
    Zhao H; Zhang ZH; Zhou B; Xiao T; Pan QJ; Guo HQ
    Diagn Cytopathol; 2015 Oct; 43(10):786-90. PubMed ID: 26152656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.